Edit Entry | Edit CV

Michael E. Zegans, MD

Title(s)
Professor of Surgery
Professor of Microbiology and Immunology

Additional Titles/Positions/Affiliations
Section Chief Ophthalmology
Francis A. L’Esperance, Jr., MD, Visual Sciences Scholar
Faculty Director, Health Professions Program, Dartmouth College 2016-22

Department(s)
Surgery
Microbiology and Immunology

Education
F.I. Proctor Foundation, UCSF, Fellow in Cornea and Uveitis 1996-1998
University of Virginia, Resident in Ophthalmology, 1993-1996
University of California - San Francisco, Mt. Zion, Medical Internship 1992-1993
University of California - San Francisco School of Medicine, MD 1992
Wesleyan University, BA 1985

Programs
Molecular Pathogenesis Program

Websites
http://www.dms.dartmouth.edu/microbio/faculty/

Academic Analytics
View Profile

Contact Information

Section of Ophthalmology
Dartmouth Hitchcock Medical Center
Lebanon NH 03756

Phone: 603-650-5123


Professional Interests

Clinical: Diseases of the cornea, ocular surface and uveitis

Surgical: Corneal transplantation, cataract surgery, conjunctival tumors

Research:
- Ocular microbiology, corneal infection and bacterial biofilm formation
- Effects of microgravity on the eye

Grant Information

RESEARCH FUNDING:
Past:
1. Medical Student Research Training Fellow 1989-90 12 calendar
(Zegans)
Howard Hughes Medical Institute
MHC-Class I Antigen Presentation
2. Continued Support Fellowship (Zegans) 1990-92 NA
Howard Hughes Medical Institute
3. Harmes Scholarship (Zegans) 2000-2003 NA Dartmouth Medical School (Surgery)
4. Hitchcock Foundation Award (Zegans) 2006-07 NA Hitchcock Foundation Inhibitors of Pseudomonas aeruginosa pilin processing
5. 5K08EY13977-4 (Zegans) 8/2002 –8/2007 9 calendar NIH/ NEI Biofilm Formation and P. aeruginosa infection of the eye
6. P20 RR16437 (Green, Director) 9/30/01-6/30/11 1.8 calendar NIHI/NCRR for pilot project Center for Molecular, Cellular, and Translational Immunology (COBRE Award)
7. AI068662-01A1(O’Toole) 9/19/07--8/31/09 3.6 calendar NIH/NIAID Zegans: key personnel
8. U10 EY015114-01A2 (Lietman) 10/2005-10/2010 1.2 calendar NIH/NEI TC for Dartmouth, Steroids for Corneal Ulcers Trial Zegans: Co- PI, Director Dartmouth study site
9. Hitchcock Foundation Pilot Grant (Zegans) 10/2012- 10/2013
Ocular surface microbiome of African children with and without ocular chlamydia infection in a trachoma-endemic area
Zegans: PI.
10. U10EY016214 subaward 7260sc (Zegans) 9/12- 8/13
NIH-NEI
TANA II- Ocular surface microbiome of African children with and without ocular chlamydia infection in a trachoma-endemic area
Role: PI
11. NCRR 1P20RR030360-01(Taylor) 9/10-04/15 0.6 calendar
NIH-NCRR New Hampshire Idea Network of Biomedical Research Excellence Zegans: Research Mentor

12. 1U10EY018573 - 01A (Lietman) 8/09-8/16 1.2 calendar NIH/NEI
Mycotic Ulcer Treatment Trial Zegans: Co-PI
NIH12ZHA002C 2/13-2/16 0.9 calendar
13. NASA/EPSCoR Integrated Modeling of Microgravity-Induced Visual Changes
Role: Co-PI
14. Norris Cotton Cancer Center (Zegans) 12/12-/6/16 0.6 calendar
Comparative Effectiveness Research
Interferon-Alpha 2b for the Treatment of Ocular Surface Squamous Neoplasia
Role: PI

Present:
1. NIH/NEI R21 EY02877-01 (Zegans) 4/18-4/20 0.15 calendar
Fungal virulence factors during corneal infections
Role: PI
2. MedImmune SRA (Zegans) 7/14-current
Anti-Ps1 mAbs / Pseudomonas Aeruginosa Collaboration (investigator initiated collaboration)
Role: PI
3. Zoster Eye Disease Study(ZEDS), NEI
Role: Co-PI, Steering Committee
4. Descemet Endothelial Thickness Comparison Trial (DETECT)
Role: Data Safety Monitoring Committee

Courses Taught

Decoding the Uveitis Workup, American Academy of Ophthalmology Instructional Course. 2001-2020

BIOL 071 - Current Topics in Cell Biology, Department of Biologic Sciences, Dartmouth College 2014

BIOL 070 - Biologic Lessons of the Eye, Department of Biologic Sciences, Dartmouth College 2016

BIOL 070 - Biologic Lessons of the Eye, Department of Biologic Sciences, Dartmouth College 2018

BIOL 070 - Biologic Lessons of the Eye, Department of Biologic Sciences, Dartmouth College 2020

BIOL 070 - Biologic Lessons of the Eye, Department of Biologic Sciences, Dartmouth College 2022

BIOL 070 - Biologic Lessons of the Eye, Department of Biologic Sciences, Dartmouth College 2023


Selected Publications

 

Characteristics of Prescreened Patients Who Did Not Participate in the Zoster Eye Disease Study.
Maja AK, Gu D, Ge L, Lopez-Jimenez C, Cohen EJ, Zegans ME
Eye Contact Lens. 2024 May 9; doi: 10.1097/ICL.0000000000001098. Epub 2024 May 9.
PMID: 38722254

Cefiderocol Is an Effective Topical Monotherapy for Experimental Extensively Drug-Resistant Pseudomonas aeruginosa Keratitis.
Romanowski EG, Mumper SM, Shanks HQ, Yates KA, Mandell JB, Zegans ME, Shanks RMQ
Ophthalmol Sci. 2024 Jul-Aug;4(4):100452. doi: 10.1016/j.xops.2023.100452. Epub 2023 Dec 13.
PMID: 38560275

Out of sight, but not out of mind: Zoster sine herpete case study and survey of Zoster Eye Disease Study (ZEDS) Group.
Sanchez G, Tsougranis G, Zheng H, Miller DM, Phan C, Jeng BH, Cohen E, Zegans ME
Am J Ophthalmol Case Rep. 2024 Mar;33:101978. doi: 10.1016/j.ajoc.2023.101978. Epub 2023 Dec 28.
PMID: 38261902

A rise in the frequency of lasR mutant Pseudomonas aeruginosa among keratitis isolates between 1993 and 2021.
Shanks RMQ, Atta S, Stella NA, Sundar-Raj CV, Romanowski JE, Grewal AS, Shanks HQ, Mumper SM, Dhaliwal DK, Mammen A, Callaghan JD, Calvario RC, Romanowski EG, Kowalski RP, Zegans ME, Jhanji V
Front Cell Infect Microbiol. 2023;13:1286842. doi: 10.3389/fcimb.2023.1286842. Epub 2023 Oct 31.
PMID: 38029269

Cefiderocol is an effective topical monotherapy for experimental extensively-drug resistant Pseudomonas aeruginosa keratitis.
Romanowski EG, Mumper SM, Shanks HQ, Yates KA, Mandell JB, Zegans ME, Shanks RMQ
bioRxiv. 2023 Sep 2; pii: 2023.08.31.555778. doi: 10.1101/2023.08.31.555778. Epub 2023 Sep 2.
PMID: 37693441

Rise in frequency of lasR mutant Pseudomonas aeruginosa among keratitis isolates between 1993 and 2021.
Shanks RMQ, Atta S, Stella NA, Sundar-Raj CV, Romanowski JE, Grewel AS, Shanks HQ, Mumper SM, Dhaliwal DK, Mammen A, Callaghan JD, Calvario RC, Romanowski EG, Kowalski RP, Zegans ME, Jhanji V
bioRxiv. 2023 Aug 22; pii: 2023.08.22.554354. doi: 10.1101/2023.08.22.554354. Epub 2023 Aug 22.
PMID: 37662319

Acute effects of postural changes and lower body positive and negative pressure on the eye.
Van Akin MP, Lantz OM, Fellows AM, Toutain-Kidd C, Zegans M, Buckey JC, Anderson AP
Front Physiol. 2022;13:933450. doi: 10.3389/fphys.2022.933450. Epub 2022 Aug 31.
PMID: 36117718

Increased Intraocular Pressure During Hemodialysis: Ocular Dialysis Disequilibrium.
Maja AK, Lewis CY, Steffen E, Zegans ME, Graber ML
Kidney Med. 2022 Sep;4(9):100526. doi: 10.1016/j.xkme.2022.100526. Epub 2022 Aug 1.
PMID: 36043165

Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.
Prajna NV, Lalitha P, Krishnan T, Rajaraman R, Radnakrishnan N, Srinivasan M, Devi L, Das M, Liu Z, Zegans ME, Acharya NR, Porco TC, Lietman TM, Rose-Nussbaumer J
JAMA Ophthalmol. 2022 Feb 1;140(2):179-184. doi: 10.1001/jamaophthalmol.2021.5765.
PMID: 35024776

Paradox of complex diversity: Challenges in the diagnosis and management of bacterial keratitis.
Singh RB, Das S, Chodosh J, Sharma N, Zegans ME, Kowalski RP, Jhanji V
Prog Retin Eye Res. 2022 May;88:101028. doi: 10.1016/j.preteyeres.2021.101028. Epub 2021 Nov 20.
PMID: 34813978

View more publications on PubMed